D.E. Shaw & Co
GBT

D.E. Shaw & Co’s Global Blood Therapeutics, Inc. GBT Stock Holding History

D.E. Shaw & Co’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-279,400
Closed -$19M – 5578
2022
Q3 		$19M Sell
279,400
-14,845
-5% -$819K 0.02% 877
2022
Q2 		$9.4M Buy
294,245
+280,843
+2,096% +$8.22M 0.01% 1442
2022
Q1 		$464K Sell
13,402
-13,421
-50% -$401K ﹤0.01% 4415
2021
Q4 		$785K Sell
26,823
-17,833
-40% -$552K ﹤0.01% 4116
2021
Q3 		$1.14M Buy
+44,656
New +$1.31M ﹤0.01% 3504
2021
Q1 		– Sell
-18,355
Closed -$795K – 4622
2020
Q4 		$795K Sell
18,355
-74,667
-80% -$3.68M ﹤0.01% 3174
2020
Q3 		$5.13M Sell
93,022
-89,178
-49% -$5.67M 0.01% 1668
2020
Q2 		$11.5M Sell
182,200
-159,535
-47% -$10.9M 0.01% 1113
2020
Q1 		$17.5M Buy
341,735
+238,735
+232% +$16M 0.03% 697
2019
Q4 		$8.19M Sell
103,000
-215,947
-68% -$12.8M 0.01% 1349
2019
Q3 		$15.5M Buy
318,947
+228,206
+251% +$11.9M 0.02% 898
2019
Q2 		$4.77M Buy
90,741
+47,918
+112% +$2.75M 0.01% 1622
2019
Q1 		$2.27M Buy
42,823
+17,662
+70% +$868K ﹤0.01% 2074
2018
Q4 		$1.03M Buy
25,161
+5,011
+25% +$188K ﹤0.01% 2637
2018
Q3 		$766K Buy
+20,150
New +$893K ﹤0.01% 2850
2018
Q2 		– Sell
-5,494
Closed -$265K – 3953
2018
Q1 		$265K Sell
5,494
-12,803
-70% -$714K ﹤0.01% 3209
2017
Q4 		$720K Buy
+18,297
New +$683K ﹤0.01% 2765
2016
Q4 		– Sell
-82,374
Closed -$1.9M – 3665
2016
Q3 		$1.9M Buy
82,374
+66,874
+431% +$1.27M ﹤0.01% 1974
2016
Q2 		$257K Sell
15,500
-642
-4% -$13K ﹤0.01% 3094
2016
Q1 		$256K Buy
+16,142
New +$287K ﹤0.01% 3083

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

D.E. Shaw & Co's GBT Position: Q4 2022 in Review

D.E. Shaw & Co sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 279,400 shares — an estimated $19M sold.

D.E. Shaw & Co first reported a position in GBT in Q1 2016 and held it in 20 quarters. The position peaked at $19M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • D.E. Shaw & Co reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • D.E. Shaw & Co sold 279,400 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $19M.
  • D.E. Shaw & Co first reported a position in Global Blood Therapeutics, Inc. in Q1 2016 and held it in 20 quarters.
  • D.E. Shaw & Co's Global Blood Therapeutics, Inc. position peaked at $19M in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on D.E. Shaw & Co's 13F filing for Q4 2022, filed 14 Feb 2023.